CorMedix Inc CRMD:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:01 PM EDT
3.38quote price arrow up+0.18 (+5.63%)
Volume
14,040
Close
3.20quote price arrow down-4.32 (-57.45%)
Volume
4,450,586
52 week range
2.65 - 8.03
Loading...
  • Open3.00
  • Day High3.59
  • Day Low3.00
  • Prev Close7.52
  • 52 Week High8.03
  • 52 Week High Date08/08/22
  • 52 Week Low2.65
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap125.18M
  • Shares Out39.12M
  • 10 Day Average Volume0.54M
  • Dividend-
  • Dividend Yield-
  • Beta2.20
  • YTD % Change-29.67

KEY STATS

  • Open3.00
  • Day High3.59
  • Day Low3.00
  • Prev Close7.52
  • 52 Week High8.03
  • 52 Week High Date08/08/22
  • 52 Week Low2.65
  • 52 Week Low Date06/16/22
  • Market Cap125.18M
  • Shares Out39.12M
  • 10 Day Average Volume0.54M
  • Dividend-
  • Dividend Yield-
  • Beta2.20
  • YTD % Change-29.67

RATIOS/PROFITABILITY

  • EPS (TTM)-0.73
  • P/E (TTM)-4.38
  • Fwd P/E (NTM)-3.69
  • EBITDA (TTM)-29.189M
  • ROE (TTM)-39.99%
  • Revenue (TTM)110,000.00
  • Gross Margin (TTM)19.20%
  • Net Margin (TTM)-25,405.63%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/11/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CorMedix Inc

There is no recent news for this security.

Profile

MORE
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's primary focus is on the development of its lead product candidate, DefenCath, for commercialization in the United States. The DefenCath/Neutrolin is an anti-infective solution, a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL intended for the...
Myron Kaplan J.D.
Independent Chairman of the Board
Joseph Todisco
Chief Executive Officer, Director
Matthew David M.D.
Chief Financial Officer, Executive Vice President
Phoebe Mounts Ph.D.
Executive Vice President, General Counsel, Head of Regulatory, Compliance and Legal
Elizabeth Masson Hurlburt
Executive Vice President - Head of Clinical Operations
Address
300 Connell Drive, Suite 4200
Berkeley Heights, NJ
07922
United States

Top Peers

SYMBOLLASTCHG%CHG
AVDL
Avadel Pharmaceuticals PLC
7.31+1.00+15.85%
SCPH
scPharmaceuticals Inc
5.50+0.15+2.80%
SEEL
Seelos Therapeutics Inc
0.8898-0.0104-1.1553%
DRRX
DURECT Corp
0.6487+0.0106+1.66%
AIMD
Ainos Inc
3.66+2.94+408.33%